Maze Therapeutics director granted 18,000 stock options
Maze Therapeutics director Charles J. Homcy received a grant of stock options covering 18,000 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Maze Therapeutics director Charles J. Homcy received a grant of stock options covering 18,000 shares of common stock. The options have an exercise price of $23.58 per share and expire on June 7, 2036. They will vest and become fully exercisable on the earlier of the company’s 2027 annual stockholders meeting or June 8, 2027, subject to his continued service.
Insider Trade Summary
Grant/Award: 18,000 shares
Grant/Award
1 txn
Insider
HOMCY CHARLES J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 18,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 18,000 contracts (Direct)
Footnotes (1)
- F1. The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date.
Key Figures
Options granted: 18,000 options
Exercise price: $23.58 per share
Expiration date: June 7, 2036
+2 more
5 metrics
Options granted
18,000 options
Stock Option (Right to Buy) grant on 2026-06-08
Exercise price
$23.58 per share
Exercise price for 18,000 underlying common shares
Expiration date
June 7, 2036
Option expiration for this grant
Total options after grant
18,000 options
Total derivative securities owned following transaction
Vesting date
Earlier of 2027 meeting or June 8, 2027
Vesting contingent on continued service
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "23.5800" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option shall vest and be fully exercisable on the earlier of..."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-06-07T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Maze Therapeutics (MAZE) disclose in this Form 4 for Charles J. Homcy?
Maze Therapeutics reported a stock option grant to director Charles J. Homcy for 18,000 shares of common stock at a $23.58 exercise price. The options represent compensation and are not an open-market purchase or sale of existing shares.
What is the exercise price of the new Maze Therapeutics (MAZE) stock options?
The options have an exercise price of $23.58 per share. This means Charles J. Homcy can purchase Maze Therapeutics common stock at $23.58 per share once the options vest and are exercised, regardless of the market price at that time.
When do Charles J. Homcy’s Maze Therapeutics (MAZE) options vest?
The options vest and become fully exercisable on the earlier of the company’s 2027 annual stockholders meeting or June 8, 2027. Vesting is conditioned on Homcy’s continued service to Maze Therapeutics through that vesting date, according to the filing footnote.
When do the newly granted Maze Therapeutics (MAZE) stock options expire?
The options expire on June 7, 2036. After this expiration date, any unexercised options become worthless and can no longer be used to purchase Maze Therapeutics common stock at the stated $23.58 exercise price.
Is this Maze Therapeutics (MAZE) Form 4 a market buy or sell by Charles J. Homcy?
No. The Form 4 reports a grant of stock options as compensation, coded as an acquisition (A), not an open-market trade. Homcy did not buy or sell existing shares in the market; he received options that may be exercised in the future.
AI-generated analysis. How Rhea-AI works. Not financial advice.
